Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

We here describe the development and validation of IMMUNO-COV™, a high-throughput clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset of anti-SARS-CoV-2 antibodies that block viral infection. The test measures the capacity of serum or purified antibodies t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Vandergaast, Rianna, Carey, Timothy, Reiter, Samantha, Lech, Patrycja, Gnanadurai, Clement, Tesfay, Mulu, Buehler, Jason, Suksanpaisan, Lukkana, Naik, Shruthi, Brunton, Bethany, Recker, Jordan, Haselton, Michelle, Ziegler, Christopher, Roesler, Anne, Mills, John R., Theel, Elitza, Weaver, Scott C., Rafael, Grace, Roforth, Matthew M., Jerde, Calvin, Tran, Sheryl, Diaz, Rosa Maria, Bexon, Alice, Baum, Alina, Kyratsous, Christos A., Peng, Kah Whye, Russell, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302210/
https://ncbi.nlm.nih.gov/pubmed/32577655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.26.117549
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados